Service de Chirurgie Digestive et Endocrinienne
Strasbourg, 67 000, France
NCT Number: NCT01760512
The purpose of this study is to gather clinical and economic evidence on the use of robotics for bariatric surgery (gastric bypass).
This monocentric, randomized, single blind, controlled study will evaluate post-operative pain, quality of life and appetite, post-operative complication incidence. It will also provide information on direct and indirect costs of surgery.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Strasbourg, 67 000, France
Robot-assisted Surgery Versus Conventional Laparoscopy in Bariatric Surgery (Gastric Bypass): a prospective, single-blind, randomized, non-inferiority, and controlled study The main evaluation criterion is 24h post-operative pain assessed using visual analog scale (VAS). Secondary criteria included for clinical assessment: post 24h pain, excess weight loss, quality of life, appetite, complications, conversion rate; and for health-economics assessment : duration of surgical steps, length of stay, return to normal activity and their conversion to cost, consumables, estimation of indirect costs and benefits (e.g., robotics perception, publication).
In this study, main inclusion criteria include major obesity (IMC ≥ 35) with co-morbidities or morbid obesity (IMC ≥ 40), scheduled gastric bypass surgery Main contraindications are previous bariatric surgery and previous major abdominal surgeries To test robotic-assisted surgery non-inferiority on VAS pain score 24h post-surgery, a total of 128 patients (64 per arm) is to be included (alpha 2,5%; power 90%; drop-out rate: 5%).
The study will include 12 months of follow-up post-surgery for each patient. The total study duration is 2 years and 3 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Gastric bypass
Time frame: 24h
Pain assessment 24h post surgery (visual analog scale)
Time frame: 24h, 8 days, 1, 3, 6 and 12 months
Evaluation of post-operative pain (beyond 24h post-operative) using VAS
Time frame: At 1, 3, 6 and 12 months
Evaluation of quality of life using BAROS and GIQLI questionaires
Time frame: At 8 days, 1, 3, 6 and 12 months
Evaluation of appetite level using VAS
Time frame: At 8 days, 1, 3, 6 and 12 months
Measure of excess weight loss - % from baseline
Time frame: During the procedure (Day 0)
Conversion rate to conventional laparoscopy (only applicable to robot-assisted surgery arm)
Time frame: During the procedure (Day 0)
Nature of per-operative complications
Time frame: Following the procedure (Day 0) up to 12 months
Nature of post-operative complications
Time frame: During the procedure (Day 0)
Evaluation of key steps of gastric bypass surgery, OR occupation time
Time frame: During the procedure (day 0) and up to 12 months
Direct costs include material used, OR occupation time, length of stay, return to normal activity
Time frame: Up to 12 months
Combination of number of patients having surgery, perception of robot-assisted surgery by both personnel and patients, publications, and communications
IHU Strasbourg
Other
Prospective, Single-blind, Randomized, Non-inferiority, and Controlled Study of Clinical and Health Economic Impact of Robot-assisted Surgery Versus Conventional Laparoscopy in Bariatric Surgery: the Case of Gastric Bypass
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07639502
Body Weight, Morbid Obesity
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06199635
Body Weight, Morbid Obesity
Santiago, Huechuraba, Región Metropolitana, Chile
View Trial DetailsNCT06268990
Body Weight, Diabetes
Graz, Austria
View Trial DetailsNCT07662538
Body Weight, Digestive System Diseases
Istanbul, Turkey (Türkiye)
View Trial Details